相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial
Julio Rosenstock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational study
Anna Norhammar et al.
DIABETES OBESITY & METABOLISM (2019)
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk The CARMELINA Randomized Clinical Trial
Julio Rosenstock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Use and effectiveness of dapagliflozin in routine clinical practice: An Italian multicentre retrospective study
Gian Paolo Fadini et al.
DIABETES OBESITY & METABOLISM (2018)
Development of SGLT1 and SGLT2 inhibitors
Timo Rieg et al.
DIABETOLOGIA (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
Silvio E. Inzucchi et al.
DIABETES CARE (2018)
Mortality Reduction Associated With -Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With Diabetes
Klaus K. Witte et al.
DIABETES CARE (2018)
T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetes
Anthony Nicolas et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Management of Blood Pressure and Heart Rate in Patients with Diabetes Mellitus
Ioanna Gouni-Berthold et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial
J. Skov et al.
DIABETES OBESITY & METABOLISM (2016)
Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin-angiotensin blockers
H. J. L. Heerspink et al.
DIABETES OBESITY & METABOLISM (2016)
Glutathione peroxidase-1 gene (GPX1) variants, oxidative stress and risk of kidney complications in people with type 1 diabetes
Kamel Mohammedi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes
Kamel Mohammedi et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Dual renin-angiotensin system blockade and outcome benefits in hypertension: a narrative review
Johannes F. E. Mann et al.
CURRENT OPINION IN CARDIOLOGY (2015)
Plasma Adrenomedullin and Allelic Variation in the ADM Gene and Kidney Disease in People With Type 2 Diabetes
Gilberto Velho et al.
DIABETES (2015)
Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes
Thiago A. Patente et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy A Randomized Clinical Trial
George L. Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Lowering blood pressure in diabetes
Seema Kang
LANCET DIABETES & ENDOCRINOLOGY (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Jackson T. Wright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Liraglutide Promotes Natriuresis but Does Not Increase Circulating Levels of Atrial Natriuretic Peptide in Hypertensive Subjects With Type 2 Diabetes
Julie A. Lovshin et al.
DIABETES CARE (2015)
Nitric oxide in the normal kidney and in patients with diabetic nephropathy
Paolo Tessari
JOURNAL OF NEPHROLOGY (2015)
Blood Pressure Lowering in Type 2 Diabetes A Systematic Review and Meta-analysis
Connor A. Emdin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
David Z. I. Cherney et al.
CIRCULATION (2014)
GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
Charles Pyke et al.
ENDOCRINOLOGY (2014)
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial
Hisatomi Arima et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
S. Zoungas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Manganese Superoxide Dismutase (SOD2) Polymorphisms, Plasma Advanced Oxidation Protein Products (AOPP) Concentration and Risk of Kidney Complications in Subjects with Type 1 Diabetes
Kamel Mohammedi et al.
PLOS ONE (2014)
The insulin receptor and the kidney
Lorna J. Hale et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2013)
Catalase activity, allelic variations in the catalase gene and risk of kidney complications in patients with type 1 diabetes
Kamel Mohammedi et al.
DIABETOLOGIA (2013)
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Lars Ryden et al.
EUROPEAN HEART JOURNAL (2013)
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study
S. E. Nielsen et al.
DIABETIC MEDICINE (2012)
Differential Effects of Nebivolol and Metoprolol on Insulin Sensitivity and Plasminogen Activator Inhibitor in the Metabolic Syndrome
Katie Ayers et al.
HYPERTENSION (2012)
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Hans-Henrik Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials
Sripal Bangalore et al.
CIRCULATION (2011)
Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
Rena R. Wing et al.
DIABETES CARE (2011)
Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial
Christian Funck-Brentano et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effects of beta-blockers on glucose and lipid metabolism
Vivian A. Fonseca
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
John J. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
William C. Cushman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials
David S. Wald et al.
AMERICAN JOURNAL OF MEDICINE (2009)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes
Toshiharu Ninomiya et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Oxidative stress as a major culprit in kidney disease in diabetes
Josephine M. Forbes et al.
DIABETES (2008)
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study):: a multicentre, randomised, double-blind, controlled trial
Johannes F. E. Mann et al.
LANCET (2008)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Long-term follow-up after tight control of blood pressure in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
A. Patel et al.
LANCET (2007)
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
K. J. Schjoedt et al.
KIDNEY INTERNATIONAL (2006)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
B Dahlöf et al.
LANCET (2005)
Forearm vascular reactivity is differentially influenced by gliclazide and glibenclamide in chronically treated type 2 diabetic patients
TC Wascher et al.
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING (2005)
Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: The NESTOR* study
M Marre et al.
JOURNAL OF HYPERTENSION (2004)
The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus:: a systematic review
MG Wulffelé et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Salt-sensitivity of proximal reabsorption alters macula densa salt and explains the paradoxical effect of dietary salt on glomerular filtration rate in diabetes mellitus
V Vallon et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and Lisinopril microalbuminuria (CALM) study
CE Mogensen et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Gliclazide scavenges hydroxyl and superoxide radicals: An electron spin resonance study
Y Noda et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
The missing link: A single unifying mechanism for diabetic complications
T Nishikawa et al.
KIDNEY INTERNATIONAL (2000)
分享论文
